← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Lucira Health, Inc
Emeryville, CA
$6,619,659
Total funding
5
Grants
Funding over time
peak $1.4M · FY2012–22$2M$1.5M$1M$500K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$6,619,659 · 5
By mechanism
R44$5,871,283 · 3
R41$599,496 · 1
R43$148,880 · 1
Investigators at Lucira Health, Inc
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Low-Cost Instrument-free Point-of-Care Test for Chlamydia and Gonorrhea$999,228
R44 · FY2020 · AI
Low-Cost Instrument-free Point-of-Care Test for Chlamydia and Gonorrhea$991,343
R44 · FY2021 · AI
Low-Cost Instrument-free Point-of-Care Test for Chlamydia and Gonorrhea$982,993
R44 · FY2022 · AI
Low-Cost Instrument-free Point-of-Care Diagnostic for Neisseria gonorrhoeae$776,968
R44 · FY2018 · AI
Low-Cost Instrument-free Point-of-Care Diagnostic for Neisseria gonorrhoeae$716,689
R44 · FY2017 · AI
Low-Cost Instrument-free Point-of-care Platform for Multiplexed Chlamydia Diagnostics$707,926
R44 · FY2016 · AI
Low-Cost Instrument-free Point-of-care Platform for Multiplexed Chlamydia Diagnostics$696,136
R44 · FY2017 · AI
Low-Cost Instrument-free Point-of-care Platform for Multiplexed Chlamydia Diagnos$299,748
R41 · FY2014 · AI
Low-Cost Instrument-free Point-of-care Platform for Multiplexed Chlamydia Diagnos$299,748
R41 · FY2015 · AI
Self-powered Integrated Microfluidic Blood Analysis System (SIMBAS) for Molecular$148,880
R43 · FY2012 · OD